These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3669949)

  • 1. Immunospecific NMR contrast agents.
    Renshaw PF; Owen CS; Evans AE; Leigh JS
    Magn Reson Imaging; 1986; 4(4):351-7. PubMed ID: 3669949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferrimagnetic susceptibility contrast agents.
    Bach-Gansmo T
    Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of ultrasmall magnetite [correction of paramagnetic magnetite] particles as superparamagnetic contrast agents in MRI.
    Grimm J; Karger N; Lüsse S; Winoto-Morbach S; Krisch B; Müller-Hülsbeck S; Heller M
    Invest Radiol; 2000 Sep; 35(9):553-6. PubMed ID: 10982000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferromagnetic contrast agents: a new approach.
    Renshaw PF; Owen CS; McLaughlin AC; Frey TG; Leigh JS
    Magn Reson Med; 1986 Apr; 3(2):217-25. PubMed ID: 3713487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-coated magnetite particles as contrast agents for MR imaging and laser therapy of human tumors.
    To SY; Castro DJ; Lufkin RB; Soudant J; Saxton RE
    J Clin Laser Med Surg; 1992 Jun; 10(3):159-69. PubMed ID: 10147859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Work in progress: potential oral and intravenous paramagnetic NMR contrast agents.
    Runge VM; Stewart RG; Clanton JA; Jones MM; Lukehart CM; Partain CL; James AE
    Radiology; 1983 Jun; 147(3):789-91. PubMed ID: 6844614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
    Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
    Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI contrast agents: Classification and application (Review).
    Xiao YD; Paudel R; Liu J; Ma C; Zhang ZS; Zhou SK
    Int J Mol Med; 2016 Nov; 38(5):1319-1326. PubMed ID: 27666161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramagnetic agents for contrast-enhanced NMR imaging: a review.
    Runge VM; Clanton JA; Lukehart CM; Partain CL; James AE
    AJR Am J Roentgenol; 1983 Dec; 141(6):1209-15. PubMed ID: 6606318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
    Luchetti A; Milani D; Ruffini F; Galli R; Falini A; Quattrini A; Scotti G; Comi G; Martino G; Furlan R; Politi LS
    Mol Imaging; 2012 Apr; 11(2):114-25. PubMed ID: 22469239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Evaluation of Gd(3+)-Anionic Linear Globular Dendrimer-Monoclonal Antibody: Potential Magnetic Resonance Imaging Contrast Agents for Prostate Cancer Cell Imaging.
    Mirzaei M; Mehravi B; Ardestani MS; Ziaee SA; Pourghasem P
    Mol Imaging Biol; 2015 Dec; 17(6):770-6. PubMed ID: 25917749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paramagnetic NMR contrast agents. Development and evaluation.
    Runge VM; Clanton JA; Foster MA; Smith FW; Lukehart CM; Jones MM; Partain CL; James AE
    Invest Radiol; 1984; 19(5):408-15. PubMed ID: 6439672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New simulation approach using classical formalism to water nuclear magnetic relaxation dispersions in presence of superparamagnetic particles used as MRI contrast agents.
    Vuong QL; Gossuin Y; Gillis P; Delangre S
    J Chem Phys; 2012 Sep; 137(11):114505. PubMed ID: 22998269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast agents for nuclear magnetic resonance imaging.
    Dias MH; Lauterbur PC
    Biol Trace Elem Res; 1987 Aug; 13(1):229-39. PubMed ID: 24254679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paramagnetic water proton relaxation enhancement: from contrast agents in MRI to reagents for quantitative "in vitro" assays.
    Aime S; Botta M; Ermondi G; Fasano M; Terreno E
    Magn Reson Imaging; 1992; 10(5):849-54. PubMed ID: 1461081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo.
    Bankert RB; Yokota S; Ghosh SK; Mayhew E; Jou YH
    Cancer Res; 1989 Jan; 49(2):301-8. PubMed ID: 2783380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast agents for magnetic resonance spectroscopy: a method to obtain increased information in in vivo and in vitro spectroscopy.
    Swartz HM; Chen K; Hu HP; Hideg K
    Magn Reson Med; 1991 Dec; 22(2):372-7; discussion 378. PubMed ID: 1812373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging.
    Gore JC; Majumdar S
    Magn Reson Med; 1990 May; 14(2):242-8. PubMed ID: 2189053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo simulation and theory of proton NMR transverse relaxation induced by aggregation of magnetic particles used as MRI contrast agents.
    Vuong QL; Gillis P; Gossuin Y
    J Magn Reson; 2011 Sep; 212(1):139-48. PubMed ID: 21807538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative MR imaging of targeted SPIO particles on the cell surface and comparison to flow cytometry.
    Peldschus K; Schultze A; Nollau P; Kaul M; Schumacher U; Wagener C; Adam G; Ittrich H
    Magn Reson Imaging; 2010 May; 28(4):599-606. PubMed ID: 20117898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.